Enanta Pharmaceuticals Inc (ENTA)
SG&A Expenses
$9.47M
Quarterly · Period ending: · USD
ENTA SG&A Expenses
Latest reported$9.47Mperiod ending
Latest reported$9.47Mperiod ending
ENTA Quarterly SG&A Expenses ($1.20M → $9.47M)
Quarterly SG&A Expenses
High-resolution chart · PNG
ENTA sg&a expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 9,469,000 | |
| 9,568,000 | |
| 9,009,000 | |
| 9,702,000 | |
| 9,997,000 | |
| 11,388,000 | |
| 12,846,000 | |
| 13,683,000 | |
| 13,414,000 | |
| 14,235,000 | |
| 16,518,000 | |
| 13,795,000 | |
| 12,618,000 | |
| 13,238,000 | |
| 12,185,000 | |
| 11,914,000 | |
| 12,213,000 | |
| 10,476,000 | |
| 9,508,000 | |
| 8,356,000 | |
| 8,477,000 | |
| 8,326,000 | |
| 7,377,000 | |
| 6,728,000 | |
| 6,823,000 | |
| 6,884,000 | |
| 6,921,000 | |
| 6,163,000 | |
| 6,151,000 | |
| 6,780,000 | |
| 7,152,000 | |
| 5,830,000 | |
| 6,135,000 | |
| 5,706,000 | |
| 5,770,000 | |
| 5,118,000 | |
| 5,233,000 | |
| 5,461,000 | |
| 4,937,000 | |
| 4,440,000 | |
| 4,282,000 | |
| 4,426,000 | |
| 3,818,000 | |
| 3,693,000 | |
| 3,643,000 | |
| 3,438,000 | |
| 2,769,000 | |
| 2,761,000 | |
| 2,603,000 | |
| 2,565,000 | |
| 2,087,000 | |
| 1,750,000 | |
| 1,788,000 | |
| 1,342,000 | |
| 1,152,000 | |
| 1,772,000 | |
| 1,145,000 | |
| 1,207,000 | |
| 1,251,000 | |
| 1,202,000 |